Inclusion Criteria:  Positive ELISA test results for HIV-1 antibodies; Hospitalized patients; Voluntarily signing the patient's informed consent and being able to promise to be followed up; No plans to move away from the current trial site during the course of the trial.  Exclusion Criteria:  Western Blot and/or HIV RNA assay confirmed as HIV negative; Women who are pregnant or breastfeeding; Current drug users; Persons with a history of alcohol abuse that cannot be terminated; Persons of non-Chinese nationality; Other patients who, in the judgment of the investigator, are deemed unsuitable for participation in this trial.